Drug-induced expansion and differentiation of Vγ9Vδ2 T cells in vivo: The role of exogenous IL-2

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1593-1598

  Casetti, Rita ^a   Perretta, Gemma ^b   Taglioni, Alessandra ^b   Mattei, Maurizio ^c   Colizzi, Vittorio ^c   Dieli, Francesco ^d   D'Offizi, Gianpiero ^a   Malkovsky, Miroslav ^e   Poccia, Fabrizio ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Institute of Neurobiology and Molecular Medicine   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY DEXTRO XYLULOSE 5 PHOSPHATE; 2,3 DIPHOSPHOGLYCERIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BROMOHYDRAZINE PYROPHOSPHATE; CD27 ANTIGEN; CD69 ANTIGEN; EPOXYMETHYLBUTYL PYROPHOSPHATE; GAMMA INTERFERON; ISOPENTYLPYROPHOSPHATE; ISOPRENOID; MEVALONIC ACID; NITROGEN; PAMIDRONIC ACID; PYROPHOSPHOMONOESTER DERIVATIVE; PYROPHOSPHORIC ACID DERIVATIVE; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; XYLULOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BLOOD; CANCER CELL; CONTROLLED STUDY; EFFECTOR CELL; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INTERFERON PRODUCTION; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MACACA; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

EID: 22544461014     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1593     Document Type: Article

References (37)

1. Barnes, P. F., C. L. Grisso, J. S. Abrams, H. Band, T. H. Rea, and R. L. Modlin. 1992. γδ lymphocytes in human tuberculosis. J. Infect. Dis. 165: 506-512.
2. Scalise, F., R. Gerli, G. Castellucci, F. Spinozzi, G. M. Fabietti, S. Crupi, L. Sensi, R. Britta, R. Vaccaro, and A. Bertotto. 1992. Lymphocytes bearing the γδ T cell receptor in acute toxoplasmosis. Immunology 76: 668-670.
3. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J. J. Fournie. 1994. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264: 267-270.
4. Bukowski, J. F., C. T. Monta, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154: 998-1006.
5. Altincicek, B., J. Moll, N. Campos, G. Foerster, E. Beck, J. F. Hoeffler, C. Grosdemange-Billiard, M. Rodriguez-Concepcion, M. Rohmer, A. Boronat, M. Eberl, and H. Jomaa. 2001. Cutting edge: human γδ T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J. Immunol. 166: 3655-3658.
6. Espinosa, E., C. Belmant, F. Pont, B. Luciani, R. Poupot, F. Romagne, H. Brailly, M. Bonneville, and J.J. Fournie. 2001. Chemical synthesis and biological activity of phosphostim, a potent stimulator of human γδ T cells. J. Biol. Chem. 276: 18337-18344.
7. Kunzmann, V., E. Bauer, J. Feurle, F. Weissinger, H. P. Tony, and M. Wilhelm. 2000. Stimulation of γδ cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96: 384-392.
8. Gober, H. J., M. Kistowska, L. Angman, H. J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori, and G. De Libero. 2003. Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197: 163-168.
9. Bukowski, J. F., C. T. Morila, and M. B. Brenner. 1994. Recognition and destruction of virus infected cells by γδ CTL. J. Immunol. 153: 5133-5140.
10. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J. J. Fournie, and M. L. Gougeon. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen reactive Vγ9Vδ2 T lymphocytes. J. Immunol. 159: 6009-6017.
11. Wallace, M., S. R. Bartz, W. L. Chang, D. A. Mackenzie, C. D. Pauza, and M. Malkovsky. 1996. γδ T lymphocyte responses to HIV. Clin. Exp. Immunol. 103: 177-184.
12. Poccia, F., L. Battistini, B. Cipriani, G. Mancino, F. Martini, M. L. Gougeon, and V. Colizzi. 1999. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J. Infect. Dis. 180: 858-861.
13. Agerberth, B., J. Charo, J. Werr, B. Olsson, F. Idali, L. Lindbom, R. Kiessling, H. Jornvall, H. Wigzell, and G. H. Gudmundsson. 2000. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96: 3086-3093.
14. Dieli, F., M. Troye-Blomberg, J. Ivanyi, J. J. Fournie, M. Bonneville, M. A. Peyrat, G. Sireci, and A. Salerno. 2000. Vγ9Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 30: 1512-1519.
15. Dieli, F., M. Troye-Blomberg, J. Ivanyi, J. J. Fournie, A. M. Krensky, M. Bonneville, M. A. Peyrat, N. Caccamo, G. Sireci, and A. Salerno. 2001. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes. J. Infect. Dis. 184: 1082-1085.
16. + T cells during mycobacterial infections. Science 295: 2255-2258.
17. Poccia, F., M. Malkovsky, A. Pollak, V. Colizzi, G. Sireci, A, Salerno, and F. Dieli. 1999. In vivo γδ cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands. Mol. Med. 5: 471-476.
18. Hoft, D. F., R. M. Brown, and S. T. Roodman. 1998. Bacille Calmette-Guerin vaccination enhances human γδ cell responsiveness to mycobacteria suggestive of a memory like phenotype. J. Immunol. 161: 1045-1054.
19. Fisch, P., E. Meuer, D. Pende, S. Rothenfusser, O. Viale, S. Kock, S. Ferrone, D. Fradelizi, G. Klein, L. Moretta, et al. 1997. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 T cells in tumor immunity. Eur. J. Immunol. 27: 3368-3379.
20. Sicard, H., T. Al Saati, G. Delsol, and J. J. Fournie. 2001. Synthetic phosphoantigens enhance human Vγ9Vδ2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol. Med. 7: 711-722.
21. Honda, S., Y. Sakamoto, M. Fujime, and R. Kitagawa. 1997. Immunohistochemical study of tumor infiltrating lymphocytes before and after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer. Int. J. Urol. 4: 68-73.
22. + T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J. Immunol. 168: 1484-1489.
23. Dieli, F., F. Poccia, M. Lipp, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno. 2003. Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 198: 391-397.
24. Martini, F., F. Poccia, D. Goletti, S. Carrara, D. Vincenti, G. D'Offizi, C. Agrati, G. Ippolito, V. Colizzi, L. P. Pucillo, and C. Montesano. 2002. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vγ9Vδ2 T cells in chronically infected patients undergoing structured treatment interruption. J. Infect. Dis. 186: 847-850.
25. Wilhelm, M., V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger, T. Ruediger, and H. P. Tony. 2003. γδ T cells for immune therapy of patients with lymphoid malignancies. Blood 102: 200-206.
26. MacDougall, A., P. Enders, G. Hatfield, D. Pauza, and E. Rakasz. 2001. Vγ2 TCR repertoire overlap in different anatomical compartments of healthy, unrelated rhesus macaques. J. Immunol. 166: 2296-2302.
27. Wang, H., H. K. Lee, J. F. Bukowski, H. Li, R. A. Mariuzza, Z. W. Chen, K. H. Nam, and C. T. Morita. 2003. Conservation of nonpeptide antigen recognition by rhesus monkey Vγ2Vδ2 T cells. J. Immunol. 170: 3696-3706.
28. Daubenberger, C. A., M. Salomon, W. Vecino, B. Hubner, H. Troll, R. Rodriques, M. E. Patarroyo, and G. Pluschk. 2001. Functional and structural similarity of Vγ9Vδ2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J. Immunol. 167: 6421-6430.
29. Montesano, C., C. Gioia, F. Martini, C. Agrati, C. Cairo, L. P. Pucillo, V. Colizzi, and F. Poccia. 2001. Antiviral activity and anergy of γδ T lymphocytes in cord blood and immunocompromised host. J. Biol. Regul. Homeost. Agents 15: 257-264.
30. Argentati, K., F. Re, A. Donnini, M. G. Tucci, C. Franceschi, B. Bartozzi, G. Bernardini, and M. Provinciali. 2002. Numerical and functional alterations of circulating γδ lymphocytes in aged people and centenarians. J. Leukocyte Biol. 72: 65-71.
31. Martini, F., R. Urso, C. Gioia, A. De Felici, P. Narciso, A. Amendola, M. G. Paglia, V. Colizzi, and F. Poccia. 2000. γδ cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology 100: 481-486.
32. Wallace, M., A. M. Scharko, C. D. Pauza, P. Fisch, K. Imaoka, S. Kawabata, K. Fujihashi, H. Kiyono, Y. Tanaka, B. R. Bloom, and M. Malkovsky. 1997. Functional γδ lymphocyte defect associated with human immunodeficiency virus infections. Mol. Med. 3: 60-71.
33. Kunzmann, V., E. Bauer, and M. Wilhelm. 1999. γδ T cell stimulation by pamidronate. N. Engl. J. Med. 340: 737-738.
34. Wang, L., A. Kamath, H. Das, L. Li, and J. F. Bukowski. 2001. Antibacterial effect of human Vγ2Vδ2 T cells in vivo. J. Clin. Invest. 108: 1349-1357.
35. Dieli, F., N. Gebbia, F. Poccia, N. Caccamo, C. Montesano, F. Fulfaro, C. Arcara, M. R. Valerio, S. Meraviglia, C. Di Sano, G. Sireci, and A. Salerno. 2003. Induction of γδ T lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 102: 2310-2311.
36. Kjeldsen-Kragh, J., A. J. Quayle, B. S. Skalhegg, M. Sioud, and O. Forre. 1993. Selective activation of resting human γδ T lymphocytes by interleukin-2, Eur. J. Immunol. 23: 2092-2099.
37. Poccia, F., M. L. Gougeon, C. Agrati, C. Montesano, F. Martini, C. D, Pauza, P. Fisch, M. Wallace, and M. Malkovsky. 2002. Innate T cell immunity in HIV infection: the role of Vγ9Vδ2 T lymphocytes. Curr. Mol. Med. 2: 769-781.